{"title":"Efficacy of King's Combined Uterine Suture in Managing Placenta Accreta: A Retrospective Analysis.","authors":"Wenqiang You, JinXiao Lin, LiPing Hu","doi":"10.12659/MSM.945826","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND Placenta accreta is a spectrum disorder that can include an abnormally adherent placenta to placental tissue that invades the endometrium and myometrium and results in hemorrhage during or after delivery. King's combined uterine suture is a combination of parauterine vascular ligation with longitudinal suturing of the lower uterine segment. This retrospective study aimed to evaluate outcomes from using King's combined uterine suture for hemostasis in 49 parturient women with placenta accreta spectrum (PAS). MATERIAL AND METHODS Clinical data of parturient women with placenta accreta in Fujian Maternal and Child Health Hospital from January 2020 to January 2023 were retrospectively collected. King's combined uterine suture ligation surgery was performed in these patients who had placenta accreta. Placenta accreta was diagnosed by the criteria for PAS. The outcomes of surgery and prognosis of newborns were analyzed. RESULTS A total of 49 parturient women were included and underwent successful intraoperative hemostasis without hysterectomy or ureteral injury. There were 4 cases of bladder rupture and 17 cases of uterine plastic surgery. The average intraoperative bleeding volume of the 49 patients was (507±162) mL. Patients had no long-term complications during postoperative follow-up. Apgar score of newborns was 9.67±0.77, and there was no asphyxia or neonatal death. CONCLUSIONS King's combined uterine suture ligation surgery is applied to placenta accreta, which not only has a definite and fast hemostatic effect, but can also effectively preserve the uterus.</p>","PeriodicalId":48888,"journal":{"name":"Medical Science Monitor","volume":"31 ","pages":"e945826"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11866680/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science Monitor","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12659/MSM.945826","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND Placenta accreta is a spectrum disorder that can include an abnormally adherent placenta to placental tissue that invades the endometrium and myometrium and results in hemorrhage during or after delivery. King's combined uterine suture is a combination of parauterine vascular ligation with longitudinal suturing of the lower uterine segment. This retrospective study aimed to evaluate outcomes from using King's combined uterine suture for hemostasis in 49 parturient women with placenta accreta spectrum (PAS). MATERIAL AND METHODS Clinical data of parturient women with placenta accreta in Fujian Maternal and Child Health Hospital from January 2020 to January 2023 were retrospectively collected. King's combined uterine suture ligation surgery was performed in these patients who had placenta accreta. Placenta accreta was diagnosed by the criteria for PAS. The outcomes of surgery and prognosis of newborns were analyzed. RESULTS A total of 49 parturient women were included and underwent successful intraoperative hemostasis without hysterectomy or ureteral injury. There were 4 cases of bladder rupture and 17 cases of uterine plastic surgery. The average intraoperative bleeding volume of the 49 patients was (507±162) mL. Patients had no long-term complications during postoperative follow-up. Apgar score of newborns was 9.67±0.77, and there was no asphyxia or neonatal death. CONCLUSIONS King's combined uterine suture ligation surgery is applied to placenta accreta, which not only has a definite and fast hemostatic effect, but can also effectively preserve the uterus.
期刊介绍:
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles in Clinical Medicine and related disciplines such as Epidemiology and Population Studies, Product Investigations, Development of Laboratory Techniques :: Diagnostics and Medical Technology which enable presentation of research or review works in overlapping areas of medicine and technology such us (but not limited to): medical diagnostics, medical imaging systems, computer simulation of health and disease processes, new medical devices, etc. Reviews and Special Reports - papers may be accepted on the basis that they provide a systematic, critical and up-to-date overview of literature pertaining to research or clinical topics. Meta-analyses are considered as reviews. A special attention will be paid to a teaching value of a review paper.
Medical Science Monitor is internationally indexed in Thomson-Reuters Web of Science, Journals Citation Report (JCR), Science Citation Index Expanded (SCI), Index Medicus MEDLINE, PubMed, PMC, EMBASE/Excerpta Medica, Chemical Abstracts CAS and Index Copernicus.